Breast cancer - Loss of PTEN predicts resistance to treatment Journal Article
| Author: | Pandolfi, P. P. |
| Article Title: | Breast cancer - Loss of PTEN predicts resistance to treatment |
| Keywords: | signal transduction; epidermal growth factor; protein kinase b; cancer survival; protein expression; treatment outcome; mutation; cancer risk; antineoplastic agents; breast cancer; epidermal growth factor receptor 2; enzyme activation; drug resistance; drug resistance, neoplasm; breast neoplasms; phosphatidylinositol 3 kinase; cancer therapy; carcinogenesis; antibodies, monoclonal; tumor suppressor proteins; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; 1-phosphatidylinositol 3-kinase; pten phosphohydrolase; receptor, erbb-2; gene dosage; tumor growth; trastuzumab; protein p110; everolimus; phosphatidylinositol 3,4,5 trisphosphate; phosphoric monoester hydrolases; rapamycin; receptor down regulation; protein p85; humans; human; female; priority journal; article |
| Journal Title: | New England Journal of Medicine |
| Volume: | 351 |
| Issue: | 22 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2004-11-25 |
| Start Page: | 2337 |
| End Page: | 2338 |
| Language: | English |
| DOI: | 10.1056/NEJMcibr043143 |
| PROVIDER: | scopus |
| PUBMED: | 15564551 |
| DOI/URL: | |
| Notes: | New Engl. J. Med. -- Cited By (since 1996):98 -- Export Date: 16 June 2014 -- CODEN: NEJMA -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
